SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH DIABETIC KIDNEY DISEASE

被引:0
|
作者
Lupusoru, Gabriela Elena [1 ,2 ]
Ailincai, Ioana-Georgiana [2 ]
Sorohan, Bogdan Marian [1 ,2 ]
Andronesi, Andreea Gabriella [1 ,2 ]
Lupusoru, Mircea [3 ]
Andronesi, Danut [4 ]
Manda, Dana [5 ]
Caragheorgheopol, Andra [5 ]
Ismail, Gener [1 ,2 ]
机构
[1] Carol Davila Univ Med & Pharm, Nephrol Dept, Bucharest, Romania
[2] Fundeni Clin Inst, Nephrol Dept, Bucharest, Romania
[3] Carol Davila Univ Med & Pharm, Physiol Dept, Bucharest, Romania
[4] Fundeni Clin Inst, Gen Surg & Liver Transplant Dept, Bucharest, Romania
[5] CI Parhon Natl Inst Endocrinol, Res Dept, Bucharest, Romania
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MO648
引用
收藏
页码:378 / 378
页数:1
相关论文
共 50 条
  • [21] Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients
    Huang, Yuli
    Zhou, Haobin
    Wu, Yu
    Yang, You
    Li, Wensheng
    Lu, Jianhua
    Hu, Yunzhao
    DISEASE MARKERS, 2017, 2017
  • [22] Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson's disease
    Witek, N.
    Joyce, J.
    Hawkins, J.
    Liu, Y.
    Ouyang, B.
    Patel, R.
    Borgia, J.
    Reiser, J.
    Hall, D.
    MOVEMENT DISORDERS, 2021, 36 : S460 - S460
  • [23] The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection
    Aslan, Sevinc
    Demirdal, Tuna
    Erbak, Huriye
    Aslan, Cem
    INFECTIOUS DISEASES, 2020, 52 (02) : 107 - 113
  • [24] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Anis Ismail
    Salim S. Hayek
    Current Cardiology Reports, 2023, 25 : 1797 - 1810
  • [25] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Ismail, Anis
    Hayek, Salim S.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (12) : 1797 - 1810
  • [26] Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease
    Velissaris, Dimitrios
    Zareifopoulos, Nicholas
    Koniari, Ioanna
    Karamouzos, Vasilios
    Bousis, Dimitris
    Gerakaris, Andreas
    Platanaki, Christina
    Kounis, Nicholas
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (03): : 133 - 142
  • [27] A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
    Spinale, Joann M.
    Mariani, Laura H.
    Kapoor, Shiv
    Zhang, Jidong
    Weyant, Robert
    Song, Peter X.
    Wong, Hetty N.
    Troost, Jonathan P.
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Kretzler, Matthias
    Nihalani, Deepak
    Holzman, Lawrence B.
    KIDNEY INTERNATIONAL, 2015, 87 (03) : 564 - 574
  • [28] Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease
    Afangbedji, Nowah
    Kumari, Namita
    Diaz, Sharmin
    Wen, Fayuan
    Taylor, James G.
    Nekhai, Sergei
    Jerebtsova, Marina
    BLOOD ADVANCES, 2023, 7 (09) : 1854 - 1857
  • [29] Serum soluble urokinase plasminogen activator receptor in adolescents: interaction of chronic pain and obesity
    Raff, Hershel
    Phillips, Jonathan M.
    Simpson, Pippa M.
    Weisman, Steven J.
    Hainsworth, Keri R.
    PAIN REPORTS, 2020, 5 (04)
  • [30] Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
    Hoybye, Charlotte
    Faseh, Laia
    Himonakos, Christos
    Pielak, Tomasz
    Eugen-Olsen, Jesper
    ENDOCRINE CONNECTIONS, 2019, 8 (06): : 772 - 779